In the News with Mike Dakkak
FDA advisory board member Kim Witczak joins ITN to discuss the lengths Big Pharma has gone to to keep adverse-effects data from the public. Kim shares her personal story as well as important knowledge gained from 20 years of advocacy work.
Follow Kim on Twitter @WoodyMatters and online at KimWitczak.com.